US Stock MarketDetailed Quotes
ARCT Arcturus Therapeutics
- 15.480
- +0.640+4.31%
Close Dec 20 16:00 ET
- 15.480
- 0.0000.00%
Post 16:13 ET
419.31MMarket Cap-6.64P/E (TTM)
15.800High14.610Low812.43KVolume14.700Open14.840Pre Close12.54MTurnover3.28%Turnover RatioLossP/E (Static)27.09MShares45.00052wk High1.60P/B383.92MFloat Cap14.30052wk Low--Dividend TTM24.80MShs Float129.710Historical High--Div YieldTTM8.02%Amplitude4.110Historical Low15.436Avg Price1Lot Size
Arcturus Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 26.67%-23.76M | -159.33%-30.14M | 84.51%-5.56M | -156.57%-18.1M | -100.39%-629K | 23.58%-32.41M | 237.98%50.81M | 26.85%-35.87M | 123.69%31.99M | 477.11%160.26M |
| Net income from continuing operations | 57.45%-6.9M | 67.24%-17.22M | -152.84%-26.82M | -417.95%-29.73M | -109.98%-11.71M | 54.00%-16.22M | -143.70%-52.55M | 199.19%50.75M | 104.59%9.35M | 403.51%117.35M |
| Operating gains losses | 388.57%202K | --388K | 100.16%53K | -3,904.83%-33.86M | --0 | 95.53%-70K | --0 | -15,052.65%-33.79M | 181.50%890K | 568.86%3.35M |
| Depreciation and amortization | 10.28%912K | 23.34%909K | 56.40%904K | 93.65%2.96M | 47.91%815K | 98.32%827K | 120.00%737K | 158.04%578K | 28.00%1.53M | 77.74%551K |
| Other non cash items | ---- | ---- | ---- | -76.90%502K | --0 | --0 | --0 | -8.06%502K | -68.91%2.17M | -497.74%-2.91M |
| Change In working capital | -4.80%-27.47M | -125.09%-23.65M | 116.45%10.22M | 158.78%7.38M | -95.91%1.45M | -34.90%-26.21M | 522.93%94.24M | -895.57%-62.09M | -138.49%-12.56M | 403.11%35.39M |
| -Change in receivables | 82.74%-6.11M | -96.69%2.97M | 105.58%5.01M | -4,959.04%-29.3M | 955.00%6.16M | -17,548.77%-35.42M | 6,110.80%89.68M | -27,591.05%-89.72M | 148.55%603K | 46.75%-720K |
| -Change in prepaid assets | 79.55%-850K | -1,485.89%-2.26M | -51.95%2.19M | 132.51%1.17M | 135.28%609K | -349.30%-4.16M | 106.79%163K | 210.30%4.55M | -53.62%-3.58M | -5,467.74%-1.73M |
| -Change in payables and accrued expense | -257.98%-7.03M | 149.71%5.05M | -51.43%6.2M | -144.64%-2.83M | -870.17%-9.89M | -24.72%4.45M | -301.83%-10.16M | 455.13%12.77M | 88.14%6.33M | 86.65%-1.02M |
| -Change in other current assets | -8.24%935K | -12.35%880K | 84.51%1.82M | 23.93%4.05M | 6.16%1.03M | 6.04%1.02M | 5.02%1M | 164.88%988K | 134.48%3.26M | --974K |
| -Change in other current liabilities | 10.61%-977K | 36.06%-688K | 3.69%-991K | 3.75%-4.31M | -10.88%-1.11M | 68.55%-1.09M | -341.80%-1.08M | -131.24%-1.03M | -231.38%-4.48M | ---1M |
| -Change in other working capital | -249.39%-13.43M | -302.41%-29.61M | -138.81%-4.01M | 362.73%38.61M | -88.05%4.65M | 140.68%8.99M | 152.68%14.63M | 378.79%10.34M | -144.81%-14.69M | 1,540.68%38.88M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 26.67%-23.76M | -159.33%-30.14M | 84.51%-5.56M | -156.57%-18.1M | -100.39%-629K | 23.58%-32.41M | 237.98%50.81M | 26.85%-35.87M | 123.69%31.99M | 477.11%160.26M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 91.85%-80K | 7.34%-328K | 65.27%-240K | 62.45%-2.9M | 77.02%-875K | 55.12%-981K | -193.65%-354K | 67.27%-691K | -126.83%-7.73M | -240.52%-3.81M |
| Net PPE purchase and sale | 91.85%-80K | 7.34%-328K | 65.27%-240K | 62.45%-2.9M | 77.02%-875K | 55.12%-981K | -193.65%-354K | 67.27%-691K | -126.83%-7.73M | -240.52%-3.81M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 91.85%-80K | 7.34%-328K | 65.27%-240K | 62.45%-2.9M | 77.02%-875K | 55.12%-981K | -193.65%-354K | 67.27%-691K | -126.83%-7.73M | -240.52%-3.81M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -96.83%693K | 2,456.38%2.4M | 108.00%2.19M | -742.50%-24.09M | -735.89%-18.66M | 1,890.16%21.84M | -63.42%94K | -8,244.05%-27.36M | -105.95%-2.86M | -1,070.43%-2.23M |
| Net issuance payments of debt | --0 | --0 | --0 | -447.28%-27.36M | -566.67%-20M | 1,100.00%20M | --0 | ---27.36M | -110.73%-5M | ---3M |
| Net common stock issuance | ---- | ---- | ---- | 48.18%609K | --0 | ---- | ---- | ---- | -20.19%411K | --0 |
| Proceeds from stock option exercised by employees | -99.11%11K | 2,456.38%2.4M | --2.19M | 54.22%2.67M | 74.87%1.34M | 233.60%1.23M | -63.42%94K | --0 | 91.80%1.73M | 233.91%768K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -96.83%693K | 2,456.38%2.4M | 108.00%2.19M | -742.50%-24.09M | -735.89%-18.66M | 1,890.16%21.84M | -63.42%94K | -8,244.05%-27.36M | -105.95%-2.86M | -1,070.43%-2.23M |
| Net cash flow | ||||||||||
| Beginning cash position | -16.65%317.21M | 4.61%345.28M | -11.44%348.89M | 5.75%393.98M | 53.93%369.05M | 33.28%380.6M | 2.58%330.05M | 5.75%393.98M | -19.53%372.57M | -42.36%239.76M |
| Current changes in cash | -100.49%-23.15M | -155.53%-28.07M | 94.35%-3.61M | -310.61%-45.09M | -113.07%-20.16M | 74.79%-11.55M | 239.69%50.55M | -25.80%-63.93M | 123.67%21.41M | 455.47%154.22M |
| End cash Position | -20.32%294.06M | -16.65%317.21M | 4.61%345.28M | -11.44%348.89M | -11.44%348.89M | 53.93%369.05M | 33.28%380.6M | 2.58%330.05M | 5.75%393.98M | 5.75%393.98M |
| Free cash flow | 28.58%-23.84M | -160.39%-30.47M | 84.14%-5.8M | -186.54%-21M | -100.96%-1.5M | 25.13%-33.39M | 238.44%50.45M | 28.52%-36.56M | 117.53%24.27M | 458.71%156.45M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data